D.A. Davidson & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
D.A. Davidson & Co's BMY Position: Q2 2026 in Review
D.A. Davidson & Co increased its Bristol-Myers Squibb (BMY) stake by 7.4% in Q2 2026, buying an estimated $1.29M and bringing the position to 325,059 shares worth $18.7M. The position accounts for 0.1% of the portfolio, ranked #160.
D.A. Davidson & Co first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $23.3M in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- D.A. Davidson & Co held 325,059 shares of Bristol-Myers Squibb worth $18.7M as of Q2 2026.
- D.A. Davidson & Co bought 22,465 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.29M.
- Bristol-Myers Squibb made up 0.1% of D.A. Davidson & Co's portfolio in Q2 2026, its #160 holding.
- D.A. Davidson & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- D.A. Davidson & Co's Bristol-Myers Squibb position peaked at $23.3M in Q1 2025.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.